B. Kurt Copper

Partner

Dallas + 1.214.969.5163

Connect:

Share

Kurt Copper represents clients in complex high-stakes litigation, particularly False Claims Act cases and disputes with commercial insurers. A significant portion of his practice involves clients in the health care, pharmaceutical, and life sciences industries. He has successfully represented hospital systems, clinical laboratories, retail pharmacies, and other clients in cases seeking hundreds of millions of dollars in claimed damages. He routinely litigates opposite the United States Department of Justice, the State of Texas and other state Attorney Generals (AGs), commercial insurers, and private relators' counsel. He is currently lead counsel for several clients in cases around the country regarding providers' use of the No Surprises Act's Independent Dispute resolution process.

Kurt recently helped lead the successful defense of a Fortune 500 company in litigation brought by Texas under the Texas Medicaid Fraud Prevention Act, where Jones Day's client secured partial summary judgment and then affirmance by the Supreme Court of Texas. He likewise recently helped obtain dismissal of cases in the Eastern District of Texas and the Southern District of Texas federal courts alleging Anti-Kickback Statute violations; qui tam actions in Virginia and Georgia federal courts that alleged violations of Medicaid billing regulations; a False Claims Act action in California federal court; and a qui tam lawsuit in Maine federal court alleging "reverse false claims."

He has also recently served as lead counsel or co-lead counsel on behalf of hospitals and other health care clients in disputes with commercial insurers across the country, including in Ohio, Michigan, Rhode Island, South Carolina, Florida, California, Virginia, Pennsylvania, New York, and Texas.

Experience

  • Health care providers secure dismissal of RICO claims asserted by commercial health insurance company invoking No Surprises ActJones Day represented several health care providers and other entities in their defense against claims asserted by Anthem Blue Cross Life and Health Insurance Company that the defendants caused the submission of claims to the No Surprises Act's Independent Dispute Resolution process that were ineligible, and that those claims created liability under the federal civil RICO statute and other theories.
  • Physician practices secure dismissal of False Claims Act claimsJones Day represented three medical practices who were defendants in a qui tam action brought under the federal False Claims Act.
  • Texas company successfully defends False Claims Act suitJones Day represented a Texas company and an individual defendant in a False Claims Act case alleging that the defendants improperly secured a Paycheck Protection Program loan.
  • Hospital pursues litigation to secure reimbursement from commercial insurerJones Day represented a hospital system bringing suit against a large health plan, contending that the hospital had provided services to over 2100 patients who were plan members and the plan had wrongfully failed to pay the contracted rates the parties had agreed upon.
  • Eight hospitals reach settlement in arbitration against large health plan for underpaymentsJones Day represented eight hospitals in an arbitration brought against a large health plan for underpayments.
  • Major southeast health system resolves claims brought by commercial insurerJones Day represented a large hospital system in a dispute with one of the major national health insurance providers.
  • Rhode Island hospital successfully resolves claims against commercial insurerJones Day represented a large hospital system's facility in Rhode Island in pursuing a commercial insurer's alleged failure to pay appropriately under the parties' Facility Participation Agreement.
  • Bon Secours Mercy Health obtains favorable settlement of FCA allegationsJones Day represented Bon Secours Mercy Health ("BSMH"), one of the nation’s largest health systems with 50 hospitals and over 60,000 employees, in a False Claims Act qui tam action brought by a private relator and the U.S. Attorney’s Office for the Southern District of Ohio.
  • California hospitals successfully resolve claims against commercial insurerJones Day represented a large hospital system’s multiple California facilities in pursuing a commercial insurer's alleged failure to pay appropriately under the parties' Facility Participation Agreements.
  • Pharmaceutical manufacturer successfully defends False Claims Act caseJones Day represented a pharmaceutical manufacturer as a defendant in a False Claims Act case alleging off-label marketing, among other things.
  • Dallas-Fort Worth based hospital system obtains dismissal of False Claim Act allegationsJones Day represented a Dallas-Fort Worth based hospital system in an investigation of claims asserted by a qui tam relator under the federal False Claims Act.
  • People's Choice Hospital successfully defends civil RICO lawsuitJones Day advised People's Choice Hospital (PCH) and its founder Dr. Seth Guterman, who were sued by Aetna in a civil RICO action in federal court in connection with a reference lab program that PCH operated in rural hospitals.
  • Leading laboratory services provider successfully resolves lengthy false claims case after obtaining partial summary judgment and multiple administrative victoriesThroughout several years of active litigation, Jones Day represented a laboratory services provider in a case alleging that the laboratory company violated the Florida False Claims Act by (1) failing to bill its "usual and customary charge" under the State's argued interpretation of that term; and (2) offering steep discounts in order to induce referrals in violation of Florida's anti-kickback statutes.
  • Hospice provider secures dismissal of False Claims Act caseJones Day successfully represented a hospice provider in a Department of Justice Investigation spurred by a qui tam lawsuit brought under the False Claims Act.
  • National retail pharmacy obtains dismissal of purported False Claims Act claimsJones Day prevailed on behalf of a national retail pharmacy on motions to dismiss two qui tam suits brought under the federal False Claims Act, Anti-Kickback Statute, and Civil Monetary Penalties Law.
  • Manufacturer of medical equipment obtains dismissal of False Claims Act qui tam action related to patent applicationsA manufacturer of medical equipment represented by Jones Day obtained dismissal of a False Claims Act qui tam action in which the relator alleged that the manufacturer lied on the patent applications for one of its medical products, making the patents invalid and unenforceable.
  • Specialty pharmacy secures dismissal of qui tam lawsuit under False Claims ActJones Day recently secured dismissal of all claims against a specialty pharmacy serving long-term care facilities in a qui tam lawsuit accusing Jones Day's client of violating the federal False Claims Act, including the FCA's recently amended prohibition on "reverse" false claims in 31 U.S.C. 3729(a)(1)(G).
  • LabCorp obtains complete dismissal of Virginia qui tam action alleging submission of false claims to MedicaidIn one of the first cases litigated under the Virginia Fraud Against Taxpayers Act, an analog to the federal False Claims Act, Jones Day represented Laboratory Corporation of America (LabCorp), a nationwide provider of health care diagnostic testing services.
  • LabCorp obtains dismissal of Georgia qui tam action alleging submission of false claims to MedicaidJones Day represented Laboratory Corporation of America (LabCorp), a nationwide provider of health care diagnostic testing services, in a case brought under the Georgia False Medicaid Claims Act, an analog to the federal False Claims Act.
  • National owner of multifamily residential and commercial apartment complexes resolves multiple claims against general contractor and design professionals for severe construction and design defectsJones Day represented a national owner of multifamily residential and commercial apartment complexes in Charlotte, North Carolina, Columbus, Ohio, and Pittsburgh, Pennsylvania, in connection with multiple claims against the general contractor and design professionals for severe construction and design defects.
    • View All

    JULY 2026 Alert

    Heightened Scrutiny: HHS Denies Recertification of New York's Medicaid Fraud Control Unit

    June 2026 Alert

    New Rule Amends No Surprises Act Dispute Process for Out-of-Network Health Care Payments

    June 2026 Alert

    DOJ Announces Accelerated Review and Enhanced Enforcement in Benefits Fraud Matters

    February 2026 Alert

    Federal Court Rules that a Defendant's Communications With Generative AI are Not Privileged

    January 2026 Alert

    False Claims Act Recoveries Reach Record $6.8 Billion in Fiscal Year 2025

    August 2025 Alert

    Coming January 2026: CMS Launches AI Program to Screen Prior Authorization Requests for Treatments

    April 2025 Alert

    Judge Blocks FDA Regulation of Laboratory-Developed Tests

    March 2025 Alert

    Federal Court Rejects False Claims Act's Draconian Penalties

    January 2025 Alert

    Immigration Enforcement Directives Create New Hurdles for Hospitals Advancing Standard Patient Care

    OCTOBER 2024 Alert

    Federal Court Holds False Claims Act's Qui Tam Provisions Unconstitutional
    View All

    Additional Speaking Engagements

    • December 2015
      The False Claims Act: New Developments and Continued Expansion
    • December 2014
      The False Claims Act: The Government's Stick and Relator's Carrot

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.